These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30585838)

  • 1. Intestinal failure-associated liver disease: causes, manifestations and therapies.
    Rochling FA; Catron HA
    Curr Opin Gastroenterol; 2019 Mar; 35(2):126-133. PubMed ID: 30585838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric intestinal failure-associated liver disease.
    Courtney CM; Warner BW
    Curr Opin Pediatr; 2017 Jun; 29(3):363-370. PubMed ID: 28333693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Failure-Associated Liver Disease.
    Pironi L; Sasdelli AS
    Clin Liver Dis; 2019 May; 23(2):279-291. PubMed ID: 30947877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.
    Mihajlovic M; Rosseel Z; De Waele E; Vinken M
    Toxicol Sci; 2024 Apr; 199(1):1-11. PubMed ID: 38383052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiome and intestinal failure-associated liver disease.
    Jiang L; Xu J; Cheng SY; Wang Y; Cai W
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):452-457. PubMed ID: 37453856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
    Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Khalaf RT; Sokol RJ
    Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal failure-associated liver disease in adult patients.
    Morgan J; Dibb M; Lal S
    Curr Opin Clin Nutr Metab Care; 2019 Sep; 22(5):383-388. PubMed ID: 31313688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
    Carter BA; Karpen SJ
    Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.
    Fousekis FS; Mitselos IV; Christodoulou DK
    Saudi J Gastroenterol; 2021; 27(1):3-12. PubMed ID: 33642350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral transplantation in patients with intestinal-failure associated liver disease: Evolving indications, graft selection, and outcomes.
    Hawksworth JS; Desai CS; Khan KM; Kaufman SS; Yazigi N; Girlanda R; Kroemer A; Fishbein TM; Matsumoto CS
    Am J Transplant; 2018 Jun; 18(6):1312-1320. PubMed ID: 29498797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.
    Cheang LY; Chong NCJ; Poh BY; Tan LB; Goh JLR; Lee MS; Tan KCT; Kadir HA; Cheah CCM; Salazar E
    Clin Nutr ESPEN; 2024 Jun; 61():140-144. PubMed ID: 38777425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.
    Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM;
    Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
    Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: insights into the bile acid-gut microbiota axis in intestinal failure-associated liver disease-redefining the treatment approach.
    Wang Y; Zheng L; Zhou Z; Yao D; Huang Y; Liu B; Duan Y; Li Y
    Aliment Pharmacol Ther; 2022 Jan; 55(1):49-63. PubMed ID: 34713470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal failure-associated liver disease: Current challenges in screening, diagnosis, and parenteral nutrition considerations.
    Tabone T; Mooney P; Donnellan C
    Nutr Clin Pract; 2024 Oct; 39(5):1003-1025. PubMed ID: 38245851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
    Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic Reticulum Stress Is Implicated in Intestinal Failure-Associated Liver Disease.
    Sharkey LM; Davies SE; Kaser A; Woodward JM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):431-6. PubMed ID: 25666021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions.
    Goulet OJ
    World Rev Nutr Diet; 2015; 112():90-114. PubMed ID: 25471806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
    Zafirovska M; Zafirovski A; Rotovnik Kozjek N
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.